For example, the RhoA-G17V mutation leading to increased activation of the RhoA-GEF Vav1 and a gain-of-function mutation in the RhoA-GEF Vav1 itself leading to increased RhoA activation, are found in T-cell lymphomas [27, 45]. Here, ARHGEF2 is linked to T-cell non-Hodgkin lymphoma.